What are the major opportunities in the Yellow Fever Vaccine market? What are the strategies for the Yellow Fever Vaccine market?

For detailed insights on the major opportunities and strategies in the Yellow Fever Vaccine market, Read More

How does the Yellow Fever Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Yellow Fever Vaccine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Yellow Fever Vaccine market growth? SWOT analysis of the Yellow Fever Vaccine market.

For detailed insights on the key dynamics influencing the Yellow Fever Vaccine market growth and SWOT analysis of the Yellow Fever Vaccine industry, Read More

Global Yellow Fever Vaccine Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Yellow Fever Vaccine Global Market Report 2025

Name: Yellow Fever Vaccine Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Powder, Liquid), By Treatment Type (Pain Management Drugs, Oral Rehydration), By Application (Routine Immunization, Travelers, Other Applications), By End-User (Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Yellow Fever Vaccine Market Overview

• Yellow Fever Vaccine market size has reached to $4.54 billion in 2024

• Expected to grow to $5.66 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%

• Growth Driver: Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel

• Market Trend: Innovative T-Cell Adaptive Booster Vaccines Enhancing Global Yellow Fever Immunity

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Yellow Fever Vaccine Market?

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas.

The main products of the yellow fever vaccine are powder and liquid. Yellow fever vaccine powder is a lyophilized (freeze-dried) form of the yellow fever vaccine, which requires reconstitution with a specific diluent before administration to provide immunity against the yellow fever virus. This involves various treatment types, such as pain management drugs and oral rehydration. This vaccine finds application in routine immunization, travelers, and others and is used by several end users, mainly hospitals, diagnostic centers, point-of-care centers, and others.

Yellow Fever Vaccine Market Size and growth rate 2025 to 2029: Graph

What Is The Yellow Fever Vaccine Market Size 2025 And Growth Rate?

The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.

What Is The Yellow Fever Vaccine Market Growth Forecast?

The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.66 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.

The forecast of 4.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. travel clinics by increasing costs of live-attenuated yellow fever vaccine (YF-Vax) sourced from France, thereby delaying travel immunization programs and raising tropical disease prevention costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Yellow Fever Vaccine Market Segmented?

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Is Driving The Yellow Fever Vaccine Market? Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel

Increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for purposes such as tourism, business, or personal reasons. International travel is rising due to increased global connectivity, economic growth, and the relaxation of travel restrictions post-pandemic. The yellow fever vaccine is required or recommended for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health regulations. For instance, in January 2024, according to the World Tourism Organization, a Spain-based agency, in 2023, there were 1.286 billion international tourists (overnight visitors) globally, while in 2022, there were 960 million international tourists (overnight visitors). This shows an increase of 326 million international tourists from 2022 to 2023. Therefore, increasing international travel is driving the growth of the yellow fever vaccine industry.

Who Are The Major Players In The Global Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

What Are The Key Trends Of The Global Yellow Fever Vaccine Market? Innovative T-Cell Adaptive Booster Vaccines Enhancing Global Yellow Fever Immunity

Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. A T-cell adaptive booster vaccine is a type of vaccine designed to enhance the immune system's memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Yellow Fever Vaccine Market? Emergex Enhances Vaccine Development Capabilities With Zosano Pharma Inc. Acquisition

In October 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, acquired the assets of Zosano Pharma Corporation for an undisclosed amount. Acquiring Zosano Pharma Inc. would benefit Emergex Vaccines Holding Limited by expanding its technological capabilities in transdermal delivery systems, enhancing its vaccine delivery methods, and accelerating the development and commercialization of innovative vaccines, including those targeting yellow fever. Zosano Pharma Inc. is a US-based pharmaceutical company that provides therapeutics and other bioactive molecules to patients using its transdermal microneedle system.

What Is The Regional Outlook For The Global Yellow Fever Vaccine Market?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Yellow Fever Vaccine Market?

The yellow fever vaccine market consists of sales of vaccine syringes, needles, and vaccine storage equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Yellow Fever Vaccine Industry?

The yellow fever vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the yellow fever vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Yellow Fever Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.74 billion
Revenue Forecast In 2034	$5.66 billion
Growth Rate	CAGR of 4.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product: Powder, Liquid 2) By Treatment Type: Pain Management Drugs, Oral Rehydration 3) By Application: Routine Immunization, Travelers, Other Applications 4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users Subsegments: 1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution 2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Yellow Fever Vaccine Market Characteristics

3. Yellow Fever Vaccine Market Trends And Strategies

4. Yellow Fever Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Yellow Fever Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Yellow Fever Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Yellow Fever Vaccine Market Growth Rate Analysis

5.4. Global Yellow Fever Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Yellow Fever Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Yellow Fever Vaccine Total Addressable Market (TAM)

6. Yellow Fever Vaccine Market Segmentation

6.1. Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Powder

Liquid

6.2. Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pain Management Drugs

Oral Rehydration

6.3. Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Routine Immunization

Travelers

Other Applications

6.4. Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Point Of Care Centers

Other End Users

6.5. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lyophilized Powder For Reconstitution

Freeze-Dried Powder For Reconstitution

6.6. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ready-To-Use Liquid Vaccine

Liquid Vaccine In Pre-Filled Syringes

7. Yellow Fever Vaccine Market Regional And Country Analysis

7.1. Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Yellow Fever Vaccine Market

8.1. Asia-Pacific Yellow Fever Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Yellow Fever Vaccine Market

9.1. China Yellow Fever Vaccine Market Overview

9.2. China Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Yellow Fever Vaccine Market

10.1. India Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Yellow Fever Vaccine Market

11.1. Japan Yellow Fever Vaccine Market Overview

11.2. Japan Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Yellow Fever Vaccine Market

12.1. Australia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Yellow Fever Vaccine Market

13.1. Indonesia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Yellow Fever Vaccine Market

14.1. South Korea Yellow Fever Vaccine Market Overview

14.2. South Korea Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Yellow Fever Vaccine Market

15.1. Western Europe Yellow Fever Vaccine Market Overview

15.2. Western Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Yellow Fever Vaccine Market

16.1. UK Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Yellow Fever Vaccine Market

17.1. Germany Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Yellow Fever Vaccine Market

18.1. France Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Yellow Fever Vaccine Market

19.1. Italy Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Yellow Fever Vaccine Market

20.1. Spain Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yellow Fever Vaccine Market

21.1. Eastern Europe Yellow Fever Vaccine Market Overview

21.2. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Yellow Fever Vaccine Market

22.1. Russia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Yellow Fever Vaccine Market

23.1. North America Yellow Fever Vaccine Market Overview

23.2. North America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Yellow Fever Vaccine Market

24.1. USA Yellow Fever Vaccine Market Overview

24.2. USA Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Yellow Fever Vaccine Market

25.1. Canada Yellow Fever Vaccine Market Overview

25.2. Canada Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Yellow Fever Vaccine Market

26.1. South America Yellow Fever Vaccine Market Overview

26.2. South America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Yellow Fever Vaccine Market

27.1. Brazil Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Yellow Fever Vaccine Market

28.1. Middle East Yellow Fever Vaccine Market Overview

28.2. Middle East Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Yellow Fever Vaccine Market

29.1. Africa Yellow Fever Vaccine Market Overview

29.2. Africa Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Yellow Fever Vaccine Market Competitive Landscape And Company Profiles

30.1. Yellow Fever Vaccine Market Competitive Landscape

30.2. Yellow Fever Vaccine Market Company Profiles

30.2.1. Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis

31. Yellow Fever Vaccine Market Other Major And Innovative Companies

31.1. WuXi Biologics

31.2. Novavax Inc.

31.3. Beijing Tiantan Biological

31.4. Bavarian Nordic A/S

31.5. Valneva SE

31.6. Biological E. Limited

31.7. Bio-Manguinhos

31.8. Instituto Butantan

31.9. Bio Farma

31.10. Panacea Biotec

31.11. Biovac

31.12. Institut Pasteur de Dakar

31.13. Ology Bioservices

31.14. Gavi

31.15. Wuhan Institute of Biological Products

32. Global Yellow Fever Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Yellow Fever Vaccine Market

34. Recent Developments In The Yellow Fever Vaccine Market

35. Yellow Fever Vaccine Market High Potential Countries, Segments and Strategies

35.1 Yellow Fever Vaccine Market In 2029 - Countries Offering Most New Opportunities

35.2 Yellow Fever Vaccine Market In 2029 - Segments Offering Most New Opportunities

35.3 Yellow Fever Vaccine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Merck and Co Inc. Financial Performance

Table 78: Sanofi S.A. Financial Performance

Table 79: GSK plc Financial Performance

Table 80: Takeda Pharmaceutical Company Financial Performance

Table 81: Lonza Group Ag Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Merck and Co Inc. Financial Performance

Figure 78: Sanofi S.A. Financial Performance

Figure 79: GSK plc Financial Performance

Figure 80: Takeda Pharmaceutical Company Financial Performance

Figure 81: Lonza Group Ag Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Pertussis Vaccine Global Market Report 2025 – By Product Type (DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine), By Vaccine Type (Whole-Cell Vaccine, Acellular...

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), B...

Conjugate Vaccine Global Market Report 2025 – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meningococcal,...

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, C...

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Impact of Tariff and Trade War on Market S...

Yellow Fever Vaccine Global Market Report 2025 – By Product (Powder, Liquid), By Treatment Type (Pain Management Drugs, Oral Rehydration), By Application (Routine Immunization, Travelers, Other Applications), By End-User...

Frequently Asked Questions

What is the definition of the Yellow Fever Vaccine market?

How will the Yellow Fever Vaccine market drivers and restraints affect the market dynamics? What forces will shape the Yellow Fever Vaccine industry going forward?

The market major growth driver - Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Yellow Fever Vaccine market?

The yellow fever vaccine market size has grown steadily in recent years. It will grow from $4.54 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology. The yellow fever vaccine market size is expected to see steady growth in the next few years. It will grow to " $5.66 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness. For further insights on this market, request a sample here

How is the Yellow Fever Vaccine market segmented?

The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes For further insights on this market, request a sample here

Which region has the largest share of the Yellow Fever Vaccine market? What are the other regions covered in the report?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Yellow Fever Vaccine market?

What are the key trends in the Yellow Fever Vaccine market?

Major trends in this market include Innovative T-Cell Adaptive Booster Vaccines Enhancing Global Yellow Fever Immunity. For further insights on this market, request a sample here.